INCYTE CORP INCYTE ORD SHS - stock earnings
0J9P.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 171.3 million USD | 919.0 million USD |
| 2023Q2 | 203.5 million USD | 954.6 million USD |
| 2023Q1 | 21.7 million USD | 808.7 million USD |
| 2022Q4 | 28.5 million USD | 926.7 million USD |
| 2021Q3 | 181.7 million USD | 813.0 million USD |
| 2021Q2 | 149.5 million USD | 705.7 million USD |
| 2021Q1 | 53.5 million USD | 604.7 million USD |
| 2020Q4 | 149.9 million USD | 789.5 million USD |
| 2020Q3 | -15.2 million USD | 620.6 million USD |
0J9P.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 340.7 million USD | 3.4 billion USD |
| 2021 | 948.6 million USD | 3.0 billion USD |
| 2020 | -295.7 million USD | 2.7 billion USD |
| 2019 | 446.9 million USD | 2.2 billion USD |
| 2018 | 109.5 million USD | 1.9 billion USD |
| 2017 | -313.1 million USD | 1.5 billion USD |
| 2016 | 104.2 million USD | 1.1 billion USD |
0J9P.L
Price: $57.12
52 week price:
Earnings Per Share: 4.20 USD
P/E Ratio: 13.82
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 115.8 million